Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND [PDF]
Frank P. Brouwers+8 more
openalex +1 more source
Dietary Interventions in Heart Failure With Preserved Ejection Fraction: A Scoping Review. [PDF]
Billingsley HE+4 more
europepmc +1 more source
Diastolic Function during Exercise in Heart Failure with a Preserved Ejection Fraction
Jeffrey L. Hastings+3 more
openalex +1 more source
Chronic Kidney Disease and Outcomes in Heart Failure With Preserved Versus Reduced Ejection Fraction [PDF]
David H. Smith+9 more
openalex +1 more source
The effect of empagliflozin on peripheral microvascular dysfunction in patients with heart failure with preserved ejection fraction. [PDF]
Mourmans SGJ+13 more
europepmc +1 more source
The cGMP Signaling Pathway as a Therapeutic Target in Heart Failure With Preserved Ejection Fraction [PDF]
Stephen J. Greene+10 more
openalex +1 more source
Empagliflozin in resistant hypertension and heart failure with preserved ejection fraction: the EMPEROR-Preserved trial. [PDF]
Böhm M+15 more
europepmc +1 more source
Exercise Intolerance in Heart Failure With Preserved Ejection Fraction
Matthew J. Maurer, P. Christian Schulze
openalex +1 more source
Contemporary Prevalence and Correlates of Incident Heart Failure with Preserved Ejection Fraction [PDF]
Jerry H. Gurwitz+10 more
openalex +1 more source